contact us
The New Brunswick, NJ-based company has received a $2.7 billion offer for its sterilization unit from Fortive and is planning to sell its LifeScan diabetes unit to Platinum Equity for $2.1 billion.
Do Not Allow Advertisers to Use My Personal information
